Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deloitte
Marketing
GLP-1s oust oncology as top late-stage pipeline value driver
For the first time in its 16-year pharma industry analysis, Deloitte found obesity drugs are the largest contributor to late-stage pipeline value.
Ben Adams
May 4, 2026 7:00am
Deloitte survey of industry execs zeroes in on tariffs, pricing
Jul 24, 2025 10:47am
Deloitte outlines key areas for biopharma to watch in 2025
Dec 26, 2024 8:00am
Pharma 'trust deficit' with consumers persists despite pandemic
May 18, 2021 5:09pm
